No Detail Found!

Breviscapine attenuates pulmonary vascular dysfunction and inflammatory injury in a rat model of acute pulmonary embolism

Author(s)
Yantao Zhang Department of General Surgery, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, China
Lili Wu Department of General Surgery, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, China
Liwen Dong Department of Cardiothoracic Surgery, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou,Zhejiang Province, China
Abstract
Acute pulmonary embolism (APE) is a fatal disease characterized by pulmonary artery obstruction, leading to endothelial dysfunction, elevated pulmonary arterial pressure, right ventricular overload, and systemic inflammation. Whether breviscapine, a flavonoid glycoside with vasoprotective, anti-inflammatory, and antioxidant activities, whether protects pulmonary vascular function in APE was investigated. Male Sprague-Dawley rats were allocated at random into sham, APE, APE + low-dose breviscapine (0.2 mg/kg/day), or APE + high-dose breviscapine (1 mg/kg/day) groups. APE was induced by intravenous infusion of polystyrene microspheres, and breviscapine was administered intraperitoneally for 48 hours. Hemodynamic parameters, including mean pulmonary arterial pressure and right ventricular hypertrophy, were assessed. Lung tissues were examined histologically and immunohistochemically for endothelial markers (CD31, ICAM- 1, VCAM-1) and inflammatory cytokines (IL-6, TNF-a, IL-10, MCP-1). APE caused marked pulmonary hypertension, right ventricular hypertrophy, endothelial injury, increased pro-inflammatory cytokines, and oxidative stress (p < 0.05 for all comparisons). Treatment with breviscapine, particularly with high dose, preserved endothelial structure, reduced proinflammatory cytokines, increased IL-10, restored endothelial markers, and corrected pulmonary hemodynamics. These results show that breviscapine maintains pulmonary vascular function and reduces inflammatory damage in APE and thus is a potential therapeutic drug.
Publication Details
Page(s) 1889-1897
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 38, Issue: 5, Year: 2025

Request the full text from PASTIC

Keywords
oxidative stress, inflammation, acute pulmonary embolism, Rat model, Breviscapine, pulmonary endothelium
References
. .. , 0(2) : .
0

Citations

0

Downloads

84

Views